Clinical applications of filgrastim and stem cell factor in vivo and in vitro.
Morstyn
G
G
Amgen, Inc., Thousand Oaks, California, USA.
Glaspy
J
J
Shpall
E J
EJ
LeMaistre
F
F
Briddell
R
R
Menchaca
D
D
Lill
M
M
Jones
R B
RB
Tami
J
J
Brown
S
S
D000818:Animals; D002478:Cells, Cultured; D002986:Clinical Trials as Topic; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D019089:Stem Cell Factor
D016298:Hematopoietic Cell Growth Factors; D011994:Recombinant Proteins; D019089:Stem Cell Factor; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim